{
    "symbol": "AZN",
    "slug": "azn",
    "display_name": "AZN",
    "category": "stocks",
    "region": "UK",
    "description": null,
    "url": "https://finscans.com/asset/azn",
    "lang": "en",
    "as_of": "2026-07-09T11:09:37+00:00",
    "stats_30d": {
        "total_signals": 1,
        "bullish": 0,
        "bearish": 1,
        "neutral": 0,
        "explicit": 1,
        "inferred": 0,
        "avg_impact": 8,
        "avg_confidence": 90,
        "last_signal_at": "2026-07-09 10:48:08",
        "article_count": 1
    },
    "top_catalysts": [
        {
            "text": "Rare trial failure of heart drug",
            "count": 1
        }
    ],
    "top_risk_factors": [
        {
            "text": "Potential positive data from other pipeline drugs",
            "count": 1
        },
        {
            "text": "Market overreaction may present a buying opportunity",
            "count": 1
        }
    ],
    "recent_signals": [
        {
            "signal_at": "2026-07-09 10:48:08",
            "sentiment": "Bearish",
            "impact_score": 8,
            "confidence_score": 90,
            "mention_type": "explicit",
            "timeframe": "short-term",
            "region": "UK",
            "reasoning": "AstraZeneca's stock plunged after a rare clinical failure for its heart drug, directly impacting the company's valuation and growth prospects.",
            "article": {
                "title": "AstraZeneca Stock Tumbles as Heart Drug Trial Fails",
                "url": "https://finscans.com/news/astrazeneca-stock-tumbles-as-heart-drug-trial-fails"
            }
        }
    ]
}